Pharming plant gets EMA approval, easing Ruconest supply pressures
Pharming receives European approval for manufacturing plant, significantly expanding capacity.
Pharming receives European approval for manufacturing plant, significantly expanding capacity.
A newly founded CDMO has outlined plans to invest $1.1bn to become the world’s biggest cell and gene therapy service provider.